Summary of the Centers for Disease Control and Prevention/National Institute of Allergy and Infectious Diseases Joint Workshop on Genital Herpes: 3-4 November 2022

被引:3
|
作者
Connolly, Kristie L. [1 ]
Bachmann, Laura [2 ]
Hiltke, Thomas [1 ]
Kersh, Ellen N. [2 ]
Newman, Lori M. [1 ]
Wilson, Lydia [1 ]
Mena, Leandro [2 ]
Deal, Carolyn [1 ]
机构
[1] NIAID, Div Microbiol & Infect Dis, NIH, 5601 Fishers Lane, Rockville, MD 20852 USA
[2] Ctrr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div Sexually Transmitted Dis Prevent, 1600 Clifton Rd NE, Atlanta, GA 30329 USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 05期
基金
美国国家卫生研究院;
关键词
SIMPLEX-VIRUS TYPE-1; UNITED-STATES; HSV-2; VACCINE; TRANSMISSION; PROTECTION; PRITELIVIR; EDUCATION; MOTHER;
D O I
10.1093/ofid/ofae230
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Genital herpes is caused by infection with herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) and currently has no cure. The disease is the second-most common sexually transmitted infection in the United States, with an estimated 18.6 million prevalent genital infections caused by HSV-2 alone. Genital herpes diagnostics and treatments are not optimal, and no vaccine is currently available. The Centers for Disease Control and Prevention and the National Institute of Allergy and Infectious Diseases convened a workshop entitled "CDC/NIAID Joint Workshop on Genital Herpes." This report summarizes 8 sessions on the epidemiology of genital herpes, neonatal HSV, HSV diagnostics, vaccines, treatments, cures, prevention, and patient advocacy perspective intended to identify opportunities in herpes research and foster the development of strategies to diagnose, treat, cure, and prevent genital herpes. This report summarizes the genital herpes workshop hosted by the Centers for Disease Control and Prevention and the National Institute of Allergy and Infectious Diseases, which focused on identifying important challenges and gaps for researchers, patients, and clinicians.
引用
收藏
页数:5
相关论文
共 28 条
  • [21] Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
    Nahid, Payam
    Dorman, Susan E.
    Alipanah, Narges
    Barry, Pennan M.
    Brozek, Jan L.
    Cattamanchi, Adithya
    Chaisson, Lelia H.
    Chaisson, Richard E.
    Daley, Charles L.
    Grzemska, Malgosia
    Higashi, Julie M.
    Ho, Christine S.
    Hopewell, Philip C.
    Keshavjee, Salmaan A.
    Lienhardt, Christian
    Menzies, Richard
    Merrifield, Cynthia
    Narita, Masahiro
    O'Brien, Rick
    Peloquin, Charles A.
    Raftery, Ann
    Saukkonen, Jussi
    Schaaf, H. Simon
    Sotgiu, Giovanni
    Starke, Jeffrey R.
    Migliori, Giovanni Battista
    Vernon, Andrew
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (07) : 853 - 867
  • [24] US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea
    Hiruy, Hiwot
    Bala, Shukal
    Byrne, James M.
    Roche, Kerian Grande
    Jang, Seong H.
    Kim, Peter
    Nambiar, Sumathi
    Rubin, Dan
    Yasinskaya, Yuliya
    Bachmann, Laura H.
    Bernstein, Kyle
    Botgros, Radu
    Cammarata, Sue
    Chaves, Ricardo L.
    Deal, Carolyn D.
    Drusano, George L.
    Duffy, Erin M.
    Eakin, Ann E.
    Gelone, Steve
    Hiltke, Thomas
    Hook III, Edward W.
    Jerse, Ann E.
    Mcneil, Candice J.
    Newman, Lori
    O'Brien, Seamus
    Perry, Caroline
    Reno, Hilary E. L.
    Romaguera, Raul A.
    Sato, Junko
    Unemo, Magnus
    Wi, Teodora E. C.
    Workowski, Kimberly
    O'May, Graeme A.
    Shukla, Sunita J.
    Farley, John J.
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [25] Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Updated Guidelines From the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America
    Masur, Henry
    Brooks, John T.
    Benson, Constance A.
    Holmes, King K.
    Pau, Alice K.
    Kaplan, Jonathan E.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (09) : 1308 - 1311
  • [26] Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation
    Reddy, Uma M.
    Davis, Jonathan M.
    Ren, Zhaoxia
    Greene, Michael F.
    OBSTETRICS AND GYNECOLOGY, 2017, 130 (01): : 10 - 28
  • [27] Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation
    Reddy, Uma M.
    Davis, Jonathan M.
    Ren, Zhaoxia
    Greene, Michael F.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2017, 72 (12) : 703 - 705
  • [28] Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation
    Smid, Marcela
    Gordon, Adam J.
    Plumb, Sam
    Plumb, Jennifer
    OBSTETRICS AND GYNECOLOGY, 2018, 131 (01): : 163 - 164